Cargando…
A CRISPR-Assisted Nonhomologous End-Joining Strategy for Efficient Genome Editing in Mycobacterium tuberculosis
New tools for genetic manipulation of Mycobacterium tuberculosis are needed for the development of new drug regimens and vaccines aimed at curing tuberculosis infections. Clustered regularly interspaced short palindromic repeat (CRISPR)–CRISPR-associated protein (Cas) systems generate a highly speci...
Autores principales: | Yan, Mei-Yi, Li, Si-Shang, Ding, Xin-Yuan, Guo, Xiao-Peng, Jin, Qi, Sun, Yi-Cheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6989103/ https://www.ncbi.nlm.nih.gov/pubmed/31992616 http://dx.doi.org/10.1128/mBio.02364-19 |
Ejemplares similares
-
Reconstitution of Mycobacterium marinum Nonhomologous DNA End Joining Pathway in Leishmania
por: Zhang, Wen-Wei, et al.
Publicado: (2022) -
Nonhomologous DNA End Joining in Cell-Free Extracts
por: Sharma, Sheetal, et al.
Publicado: (2010) -
Efficient processing of abasic sites by bacterial nonhomologous end-joining Ku proteins
por: de Ory, Ana, et al.
Publicado: (2014) -
Inhibition of nonhomologous end joining‐mediated DNA repair enhances anti‐HBV CRISPR therapy
por: Murai, Kazuhiro, et al.
Publicado: (2022) -
End-bridging is required for pol μ to efficiently promote repair of noncomplementary ends by nonhomologous end joining
por: Davis, Bryan J., et al.
Publicado: (2008)